R&D Systems™ Recombinant Human Lymphotoxin alpha1/beta2 Avi Protein

Catalog No.	Quantity
AVI8884025	25 μg

Catalog No. AVI8884025 Supplier R&D Systems™ Supplier No. AVI8884025

Description

Measured by its binding ability in a functional ELISA.

When Recombinant Human Lymphotoxin beta R Fc Chimera is immobilized at 25 ng/mL (100 μL/well), the concentration of Biotinylated Recombinant Human Lymphotoxin alpha1/beta2 His-tag Avi-tag that produces 50% of the optimal binding response is 0.75 to 4.5 ng/mL.

Specifications

• Accession Number: P01374 (alpha) & Q06643-1 (beta)
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 4049
• Molecular Weight (g/mol): 69 to 80 kDa
• Quantity: 25 μg
• Source: Human embryonic kidney cell, HEK293-derived human Lymphotoxin protein. Human Lymphotoxin alpha (Leu35-Leu205) Accession # P01374GGGGS. Human Lymphotoxin beta (Gln49-Gly244) Accession # Q06643-1GGGGS. Human Lymphotoxin beta (Gln49-Gly244) Accession # Q06643-1HHHHHH, Avi-tagN-terminus
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Endotoxin Concentration: < 0.10 EU per 1 μg of the protein by the LAL method
• Conjugate: Biotin
• Species: Human
• Reconstitution: Reconstitute at 500 μg/mL in PBS
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose
• Purity or Quality Grade: > 95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining